What Are GLP-1 Receptor Agonists?
GLP-1 receptor agonists are injectable or oral medications originally developed for type 2 diabetes and weight management. They mimic the hormone glucagon-like peptide-1, which helps regulate blood sugar, appetite, and digestion. Common examples include semaglutide and liraglutide.
GLP-1 and Depression: Current Evidence
Researchers are studying whether GLP-1 drugs may improve depressive symptoms. Some clinical trials suggest that weight loss and metabolic improvements can positively affect mood. A large observational study found lower rates of depression in people using these medications, though it did not prove causation. Scientists believe GLP-1 receptors in the brain may influence mood and inflammation.
Should You Consider GLP-1 for Depression?
GLP-1 medications are not approved treatments for depression. They are prescribed for diabetes, obesity, or cardiovascular risk reduction. People with depression should consult a healthcare provider for evidence-based therapies like psychotherapy or antidepressants. Using GLP-1 drugs off-label for depression requires medical supervision and further research.
